Award
NIH Reporter #5R01CA283364-04
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
Recipient
Not specified
Award Amount
$719,415.00
Ceiling
$719,415.00
Awarded
July 09, 2026
Identifier
5R01CA283364-04
Award for developing synthetic intron technology targeting RNA splicing mutations in leukemia, funded by NIH/NCI to advance cancer therapeutics.
Description
The project focuses on developing synthetic intron technology to target RNA splicing mutations in leukemia. The award is from the NIH/NCI, with a focus on cancer therapeutics. The project involves interdisciplinary collaboration among experts in cancer biology, RNA splicing, and drug delivery. The work aims to create specific therapeutic products for cancers with few effective treatments.